ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
This is a report of 30 years old woman suffering from Crohn’s disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonstrates...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Peytchinski Publishing
2016-12-01
|
Series: | Journal of IMAB |
Subjects: | |
Online Access: | http://www.journal-imab-bg.org/issues-2016/issue4/JofIMAB-2016-22-4p1389-1391.pdf |
_version_ | 1818118830203863040 |
---|---|
author | Ivaylo Vazharov Hristo Bozov Snezha Zlateva Georgi Bonchev |
author_facet | Ivaylo Vazharov Hristo Bozov Snezha Zlateva Georgi Bonchev |
author_sort | Ivaylo Vazharov |
collection | DOAJ |
description | This is a report of 30 years old woman suffering from Crohn’s disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonstrates rapid response to adalimumab in incidence of losing efficacy to another tumor necrotic factor - alpha (TNF- alpha) antagonist. |
first_indexed | 2024-12-11T05:00:32Z |
format | Article |
id | doaj.art-ac0bb11062114a6ab4f02eef0ead3777 |
institution | Directory Open Access Journal |
issn | 1312-773X |
language | English |
last_indexed | 2024-12-11T05:00:32Z |
publishDate | 2016-12-01 |
publisher | Peytchinski Publishing |
record_format | Article |
series | Journal of IMAB |
spelling | doaj.art-ac0bb11062114a6ab4f02eef0ead37772022-12-22T01:20:10ZengPeytchinski PublishingJournal of IMAB1312-773X2016-12-012241389139110.5272/jimab.2016224.1389ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case reportIvaylo Vazharov0Hristo Bozov1Snezha Zlateva2Georgi Bonchev3Clinic of Internal diseases, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic of Anaesthesiology, Marine and Intensive medicine, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Military Medical Academy, Bulgaria.Clinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Military Medical Academy, Bulgaria.This is a report of 30 years old woman suffering from Crohn’s disease who had a good clinical response to Infliximab (Remicade) at first, but during the treatment after 5 months she lost response. After receiving Adalimumab (Humira) clinical remission was reached on the day 20. The case demonstrates rapid response to adalimumab in incidence of losing efficacy to another tumor necrotic factor - alpha (TNF- alpha) antagonist.http://www.journal-imab-bg.org/issues-2016/issue4/JofIMAB-2016-22-4p1389-1391.pdfCrohn's diseaseTNF- alpha inhibitorsadalimumabinfliximab |
spellingShingle | Ivaylo Vazharov Hristo Bozov Snezha Zlateva Georgi Bonchev ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report Journal of IMAB Crohn's disease TNF- alpha inhibitors adalimumab infliximab |
title | ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report |
title_full | ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report |
title_fullStr | ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report |
title_full_unstemmed | ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report |
title_short | ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report |
title_sort | adalimumab induction and maintaining remission for crohn s disease in patient who lost response to infliximab case report |
topic | Crohn's disease TNF- alpha inhibitors adalimumab infliximab |
url | http://www.journal-imab-bg.org/issues-2016/issue4/JofIMAB-2016-22-4p1389-1391.pdf |
work_keys_str_mv | AT ivaylovazharov adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport AT hristobozov adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport AT snezhazlateva adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport AT georgibonchev adalimumabinductionandmaintainingremissionforcrohnsdiseaseinpatientwholostresponsetoinfliximabcasereport |